These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33786806)

  • 1. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75
    Simmons DA; Mills BD; Butler Iii RR; Kuan J; McHugh TLM; Akers C; Zhou J; Syriani W; Grouban M; Zeineh M; Longo FM
    Neurotherapeutics; 2021 Apr; 18(2):1039-1063. PubMed ID: 33786806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
    Simmons DA; Belichenko NP; Ford EC; Semaan S; Monbureau M; Aiyaswamy S; Holman CM; Condon C; Shamloo M; Massa SM; Longo FM
    Hum Mol Genet; 2016 Nov; 25(22):4920-4938. PubMed ID: 28171570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
    Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
    Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
    Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
    Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute administration of the small-molecule p75(NTR) ligand does not prevent hippocampal neuron loss or development of spontaneous seizures after pilocarpine-induced status epilepticus.
    Grabenstatter HL; Carlsen J; Raol YH; Yang T; Hund D; Cruz Del Angel Y; White AM; Gonzalez MI; Longo FM; Russek SJ; Brooks-Kayal AR
    J Neurosci Res; 2014 Oct; 92(10):1307-18. PubMed ID: 24801281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.
    Nguyen TV; Shen L; Vander Griend L; Quach LN; Belichenko NP; Saw N; Yang T; Shamloo M; Wyss-Coray T; Massa SM; Longo FM
    J Alzheimers Dis; 2014; 42(2):459-83. PubMed ID: 24898660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.
    Yang T; Tran KC; Zeng AY; Massa SM; Longo FM
    Sci Rep; 2020 Nov; 10(1):20322. PubMed ID: 33230162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery.
    Nguyen TV; Crumpacker RH; Calderon KE; Garcia FG; Zbesko JC; Frye JB; Gonzalez S; Becktel DA; Yang T; Tavera-Garcia MA; Morrison HW; Schnellmann RG; Longo FM; Doyle KP
    J Pharmacol Exp Ther; 2022 Feb; 380(2):126-141. PubMed ID: 34893553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model.
    Knowles JK; Simmons DA; Nguyen TV; Vander Griend L; Xie Y; Zhang H; Yang T; Pollak J; Chang T; Arancio O; Buckwalter MS; Wyss-Coray T; Massa SM; Longo FM
    Neurobiol Aging; 2013 Aug; 34(8):2052-63. PubMed ID: 23545424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.
    Friesland A; Weng Z; Duenas M; Massa SM; Longo FM; Lu Q
    Neurotoxicology; 2014 Dec; 45():81-90. PubMed ID: 25277379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice.
    Xie Y; Seawell J; Boesch E; Allen L; Suchy A; Longo FM; Meeker RB
    Exp Neurol; 2021 Jan; 335():113489. PubMed ID: 33007293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.
    Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM
    PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury.
    Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK
    J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.
    Shanks HRC; Chen K; Reiman EM; Blennow K; Cummings JL; Massa SM; Longo FM; Börjesson-Hanson A; Windisch M; Schmitz TW
    Nat Med; 2024 Jun; 30(6):1761-1770. PubMed ID: 38760589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting p75 neurotrophin receptors ameliorates spinal cord injury-induced detrusor sphincter dyssynergia in mice.
    Zabbarova IV; Ikeda Y; Carder EJ; Wipf P; Wolf-Johnston AS; Birder LA; Yoshimura N; Getchell SE; Almansoori K; Tyagi P; Fry CH; Drake MJ; Kanai AJ
    Neurourol Urodyn; 2018 Nov; 37(8):2452-2461. PubMed ID: 29806700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.
    Yang T; Liu H; Tran KC; Leng A; Massa SM; Longo FM
    Acta Neuropathol Commun; 2020 Sep; 8(1):156. PubMed ID: 32891185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages.
    Mirzahosseini G; Sinha N; Zhou L; Godse S; Kodidela S; Singh UP; Ishrat T; Kumar S
    Exp Biol Med (Maywood); 2024; 249():10123. PubMed ID: 39119118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.